Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Cell Transplantation Recipient”

148 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 148 results

Testing effectiveness (Phase 2)Looking for participantsNCT05086003
What this trial is testing

Combined Kidney and Hematopoietic Stem Cell Transplantation for Tolerance Induction

Who this might be right for
Renal Transplantation
Rabin Medical Center 20
Large-scale testing (Phase 3)Study completedNCT02137772
What this trial is testing

Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)

Who this might be right for
Prevention of CMV Infection or Disease
Merck Sharp & Dohme LLC 570
Large-scale testing (Phase 3)UnknownNCT04674345
What this trial is testing

Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemia

Who this might be right for
Acute LeukemiaRelapseHematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 346
Not applicableUnknownNCT04024618
What this trial is testing

Feasibility Study Comparing Enteral vs Parenteral Nutritional Outcomes in Autologous Stem Cell Transplant Patients

Who this might be right for
Malignant Hematologic Neoplasm
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 40
Not applicableNot Yet RecruitingNCT07644481
What this trial is testing

Efficacy and Safety of the CloB2M (Clofarabine Combined With Busulfan and Melphalan) Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients With Acute Myeloid Leukemia in First Complete Remission

Who this might be right for
AML (Acute Myelogenous Leukemia)Allogeneic Hematopoietic Stem Cell Transplantation Recipient
Institute of Hematology & Blood Diseases Hospital, China 30
Testing effectiveness (Phase 2)Study completedNCT03583424
What this trial is testing

Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Hematopoietic Cell Transplantation RecipientRecurrent Diffuse Large B-Cell LymphomaRecurrent Grade 1 Follicular Lymphoma+9 more
Ohio State University Comprehensive Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT03267186
What this trial is testing

Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+2 more
Andrew Rezvani 8
Not applicableUnknownNCT00587574
What this trial is testing

Prospective Phase II Study for Assessment of Regulatory Immune Cell Populations After Allogeneic HSCT

Who this might be right for
Allogeneic Hematopoietic Cell Transplant Recipients
Medical University of Vienna 150
Not applicableStudy completedNCT05789615
What this trial is testing

Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China

Who this might be right for
CMV InfectionHematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University 200
Testing effectiveness (Phase 2)Study completedNCT04339062
What this trial is testing

Cemiplimab in AlloSCT/SOT Recipients With CSCC

Who this might be right for
Cutaneous Squamous Cell CarcinomaAdvanced Cancer
Dana-Farber Cancer Institute 12
Testing effectiveness (Phase 2)Ended earlyNCT03715023
What this trial is testing

Anti-viral Effect of PC786 on RSV Infection on HSCT Recipients

Who this might be right for
Respiratory Syncytial Virus Infections
Pulmocide Ltd 5
Not applicableStudy completedNCT04549038
What this trial is testing

Time Restricted Nutrition in Pediatric Stem Cell Transplant Recipients

Who this might be right for
Hematopoietic Stem Cell Transplant
Children's Hospital Medical Center, Cincinnati 21
Not applicableUnknownNCT06242496
What this trial is testing

Brain Abscesses in Transplant Recipients: a Multicentre Retrospective Study (BAT-STUDY)

Who this might be right for
Brain Abscess
Assistance Publique - Hôpitaux de Paris 200
Testing effectiveness (Phase 2)Ended earlyNCT01640301
What this trial is testing

Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Recurrent Adult Acute Myeloid LeukemiaRecurrent Childhood Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia+5 more
Fred Hutchinson Cancer Center 47
Not applicableStudy completedNCT00079222
What this trial is testing

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cancer
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Temporarily pausedNCT03494569
What this trial is testing

Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia+5 more
City of Hope Medical Center 36
Not applicableNot Yet RecruitingNCT07286461
What this trial is testing

VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientCMV
University of Rome Tor Vergata 290
Testing effectiveness (Phase 2)Ended earlyNCT01629511
What this trial is testing

Allogeneic Stem Cell Transplant for CLL

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientChronic Lymphocytic LeukemiaProlymphocytic Leukemia+1 more
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT01665677
What this trial is testing

Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft vs Host Disease
Mehdi Hamadani 69
Not applicableStudy completedNCT05825833
What this trial is testing

Infliximab Efficacy in Relation to Therapeutic Drug Monitoring and Serum TNFα Levels in Pediatric HSCT

Who this might be right for
Acute Graft-versus-host Disease
IRCCS Burlo Garofolo 28
Next Page